Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07234188

POM vs HFNC for Hypoxemia Prevention in Children

Comparison of a Procedural Oxygen Mask and High-Flow Nasal Cannula for the Prevention of Hypoxemia During Pediatric Upper Gastrointestinal Endoscopy Under Sedation: A Single-Center Randomized Controlled Pilot Trial

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
30 (estimated)
Sponsor
Bedirhan Günel · Other Government
Sex
All
Age
6 Years – 16 Years
Healthy volunteers
Not accepted

Summary

Upper gastrointestinal endoscopy is a commonly performed diagnostic and therapeutic procedure in children, allowing evaluation of the esophagus, stomach, and duodenum, as well as interventions such as biopsy, foreign body removal, and polypectomy. Sedation is routinely used, often at greater depths than for standard examinations. Due to anatomical and physiological differences, including smaller airway diameter, higher oxygen consumption, and lower functional residual capacity, pediatric patients are at higher risk of airway obstruction, hypoxemia, and hypoventilation compared to adults. The passage of the endoscope through the mouth further limits airway access and increases the risk of desaturation. Oxygenation during pediatric endoscopy is typically supported using nasal cannulas, high-flow systems, or procedural oxygen masks (POM™). This pilot randomized study aims to compare POM™ and high-flow nasal cannula in preventing hypoxemia during sedated pediatric upper gastrointestinal endoscopy, contributing evidence for safer sedation and airway management practices in children.

Conditions

Interventions

TypeNameDescription
DEVICEProcedural Oxygen MaskDelivers oxygen through the mouth and nose during sedation while allowing endoscope passage.
DEVICEHigh-Flow Nasal CannulaOxygen delivered via HFNC at 30 L/min, 35 °C, targeting FiO₂ 95% during the procedure.

Timeline

Start date
2026-03-04
Primary completion
2026-05-31
Completion
2026-05-31
First posted
2025-11-18
Last updated
2026-03-06

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT07234188. Inclusion in this directory is not an endorsement.